1. Schmitt, Thomas, Hudemann, Christoph, Moztarzadeh, Sina, Tikkanen, Ritva, Waschke, Jens. 2023. Dsg3 epitope-specific signalling in pemphigus. In Frontiers in immunology, 14, 1163066. doi:10.3389/fimmu.2023.1163066. https://pubmed.ncbi.nlm.nih.gov/37143675/
2. Lee, Jinmin, Lundgren, Daniel K, Mao, Xuming, Milone, Michael C, Payne, Aimee S. . Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris. In The Journal of clinical investigation, 130, 6317-6324. doi:10.1172/JCI138416. https://pubmed.ncbi.nlm.nih.gov/32817591/
3. Viehweger, Florian, Azem, Ahmad, Gorbokon, Natalia, Menz, Anne, Hinsch, Andrea. 2022. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. In Pathology, research and practice, 240, 154200. doi:10.1016/j.prp.2022.154200. https://pubmed.ncbi.nlm.nih.gov/36375372/
4. Chi, Zhikai, Balani, Jyoti, Gopal, Purva, Lewis, Cheryl M, Peng, Lan. 2022. Characterization of Desmoglein 3 (DSG3) as a Sensitive and Specific Marker for Esophageal Squamous Cell Carcinoma. In Gastroenterology research and practice, 2022, 2220940. doi:10.1155/2022/2220940. https://pubmed.ncbi.nlm.nih.gov/35251162/
5. Schmitt, Thomas, Pircher, Julia, Steinert, Letyfee, Kugelmann, Daniela, Waschke, Jens. 2022. Dsg1 and Dsg3 Composition of Desmosomes Across Human Epidermis and Alterations in Pemphigus Vulgaris Patient Skin. In Frontiers in immunology, 13, 884241. doi:10.3389/fimmu.2022.884241. https://pubmed.ncbi.nlm.nih.gov/35711465/
6. Chen, Y-J, Chang, J T, Lee, L, Chen, P-J, Cheng, A-J. 2006. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. In Oncogene, 26, 467-76. doi:. https://pubmed.ncbi.nlm.nih.gov/16878157/
智鼠故事 
